Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
127.50    5.25 (4.29%)
Bid:
128.50
Ask:
129.50
Spread: 1.00 (0.778%)
Market Cap: £203.13m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

23 Dec 2020 07:00

RNS Number : 6037J
Redcentric PLC
23 December 2020
 

Redcentric plc

 

Director/PDMR Shareholding, Issue of Equity and Total Voting Rights

 

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that on 22 December 2020 it received notification of exercise from each of Peter Brotherton, Chief Executive Officer, and David Senior, Chief Financial Officer, in relation to nil-cost share options ("Options") over ordinary shares of 0.1p each in the Company ("Ordinary Shares"), pursuant to the Company's 2017 Long Term Incentive Plan (the "Exercise"), as follows:

· Peter Brotherton exercised 192,481 Options. Following the Exercise, Mr Brotherton sold 97,481 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Brotherton holds 228,571 Ordinary Shares in the Company (representing approximately 0.15% of the Company's issued share capital) and 921,061 share options in the Company;

· David Senior exercised 29,100 Options. Following the Exercise, Mr Senior sold 14,550 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Senior holds 43,121 Ordinary Shares in the Company (representing approximately 0.03% of the Company's issued share capital) and 249,555 shares options in the Company.

Accordingly, application has been made for 221,581 new Ordinary Shares to be issued pursuant to the option exercise to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around the 31 December 2020.

Following Admission, the Company's issued share capital will consist of 156,165,710 Ordinary Shares, 37,569 of which are held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any shares held in Treasury and should use the figure of 156,128,141 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

Following the Exercise there are options outstanding over 3,891,750 Ordinary Shares, representing 2.49% of the Company's issued share capital.

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

finnCap Ltd - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Brotherton

 

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

192,481 options exercised

22 December 2020

110p

97,481 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Senior

 

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

29,100 options exercised

22 December 2020

110p

14,550 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTTBJTMTTTTPM
Date   Source Headline
9th Jun 20207:00 amRNSExtension of bank facilities
12th May 20203:22 pmRNSHolding(s) in Company
3rd Apr 20207:01 amRNSBoard Changes
3rd Apr 20207:00 amRNSTrading update and COVID-19 update
19th Mar 20205:48 pmRNSTransaction in Own Shares
17th Mar 20205:41 pmRNSTransaction in Own Shares
16th Mar 20205:15 pmRNSTransaction in Own Shares
27th Feb 20207:00 amRNSTransaction in Own Shares
13th Jan 20207:00 amRNSChange of Adviser
28th Nov 20197:00 amRNSHalf Year Results
20th Nov 20195:06 pmRNSTransaction in Own Shares
5th Nov 20195:02 pmRNSTransaction in Own Shares
30th Oct 20195:18 pmRNSTransaction in Own Shares
29th Oct 20197:00 amRNSTransaction in Own Shares
25th Oct 20195:23 pmRNSTransaction in Own Shares
17th Oct 20197:00 amRNSBoard Changes
9th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Sep 20195:57 pmRNSTransaction in Own Shares
17th Sep 20197:00 amRNSShare Buyback Programme
4th Sep 20192:30 pmRNSIssue of Options
2nd Sep 20191:03 pmRNSResult of AGM
30th Aug 20194:27 pmRNSDirector Shareholding
30th Aug 20194:19 pmRNSSave As You Earn Share Option Scheme
20th Aug 201911:00 amRNSDirectorate Change
14th Aug 20197:00 amRNSExercise of Options
2nd Aug 20197:00 amRNSPublication of Annual Report and Notice of AGM
17th Jul 20193:48 pmRNSDividend Dates
17th Jul 20197:00 amRNSChange of Dividend Dates
1st Jul 20193:58 pmRNSIssue of Options
25th Jun 20197:00 amRNSPreliminary Results Announcement FY19
28th May 20197:00 amRNSDirectorate Change
15th Apr 20197:00 amRNSTrading update and notice of results date
26th Feb 20192:58 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSDirectorate Change
5th Dec 20184:01 pmRNSDirector/PDMR Shareholding
28th Nov 20183:12 pmRNSHolding(s) in Company
27th Nov 20183:31 pmRNSHolding(s) in Company
22nd Nov 20187:01 amRNSDirectorate Change
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:00 pmRNSHolding(s) in Company
4th Oct 20187:00 amRNSPre-Close Statement
3rd Sep 20186:05 pmRNSResult of AGM
9th Aug 201811:52 amRNSPublication of Annual Report and Notice of AGM
13th Jul 201810:14 amRNSHolding(s) in Company
12th Jul 20185:01 pmRNSHolding(s) in Company
5th Jul 20182:45 pmRNSHolding(s) in Company
28th Jun 20187:00 amRNSPreliminary Results Announcement FY18
26th Jun 20185:03 pmRNSHolding(s) in Company
8th Jun 20182:50 pmRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.